Identifying another piece in the Parkinson's disease pathology puzzle

An international consortium identifies and validates cellular role of priority Parkinson’s disease drug target, LRRK2 kinase, in a new study, illuminating a novel route for therapeutic development and intervention testing for Parkinson’s, the second most common neurodegenerative disease after Alzheimer’s.

Source:: Science Daily

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *